Clinical Trial Update: Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 study completed and explored how 12-lipoxygenase affects platelet reactivity in patients with Type 2 Diabetes Mellitus and thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Michigan | Conditions: Thrombosis, Type 2 Diabetes Mellitus | EARLY_Phase 1 | Status: COMPLETED